Benefits, cost requirements and cost-effectiveness of the HPV16, 18 vaccine for cervical cancer prevention in developing countries: policy ... An article from: Reproductive Health Matters

This digital document is an article from Reproductive Health Matters, published by Reproductive Health Matters on November 1, 2008. The length of the article is 6223 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available immediately after purchase. You can view it with any web browser.

Citation Details
Title: Benefits, cost requirements and cost-effectiveness of the HPV16, 18 vaccine for cervical cancer prevention in developing countries: policy implications.(Clinical report)
Author: Sue J. Goldie
Publication:Reproductive Health Matters (Magazine/Journal)
Date: November 1, 2008
Publisher: Reproductive Health Matters
Volume: 16 Issue: 32 Page: 86(11)

Article Type: Clinical report

Distributed by Gale, a part of Cengage Learning